Embedded Files
The Center for Prostate Disease Research (CPDR) is a multidisciplinary translational research program within the USU Department of Surgery, and the John P. Murtha Cancer Center, focused on studying prostate cancer and prostate disease in the US Military Healthcare System. Established by Congress in 1992, CPDR fulfills its mission primarily through three principal programs: the Clinical Translational Research Center, the Basic Science Research Program, and the Tri-Service Multicenter Prostate Cancer Database.
These programs enable CPDR to conduct clinical research in collaboration with various military medical centers. CPDR consists of the comprehensive medical treatment and patient education clinic, located at Walter Reed National Military Medical Center (WRNMMC), and the state-of-the-art Dr. David G. McLeod Laboratory in Bethesda, MD.
The combined expertise of medical oncologists, research nurses and patient educators, scientists, genitourinary pathologists, biostatisticians, histologists and technicians allow for advanced technological resources and innovative collaborative research in prostate cancer and prostate disease.
These programs enable CPDR to conduct clinical research in collaboration with various military medical centers. CPDR consists of the comprehensive medical treatment and patient education clinic, located at Walter Reed National Military Medical Center (WRNMMC), and the state-of-the-art Dr. David G. McLeod Laboratory in Bethesda, MD.
The combined expertise of medical oncologists, research nurses and patient educators, scientists, genitourinary pathologists, biostatisticians, histologists and technicians allow for advanced technological resources and innovative collaborative research in prostate cancer and prostate disease.
CPDR 2nd Annual Scientific Retreat Group Photo, April 17, 2025, HJF Headquarters, Bethesda, MD
CPDR 2025 NEWS
CPDR 2025 NEWS
CPDR Hosts 2nd Annual Scientific Retreat at HJF Headquarters
April 17, 2025
The CPDR 2nd Annual Scientific Retreat took place on Thursday, April 17 at HJF HQ in Bethesda, and we hosted 150 participants both in-person and virtually. The event included ten distinguished speakers, national leaders in prostate cancer research, and four young scientists from Johns Hopkins University and CPDR. The highlight was the Keynote Address presented by Dr. Isla Garraway, from the University of California Los Angeles David Geffen School of Medicine and the VA Healthcare System, entitled: The VA Multi-OMICS Analysis Platform for Prostate Cancer (VA-MAPP) - Activating a Learning Healthcare System Model to Improve Outcomes for Veterans. The day's agenda featured four insightful sessions covering critical research areas: Genomics of Prostate Cancer, Tumor Immune Microenvironment, Next Generations Cancer Therapeutics, and Advance Molecular Biology of Lethal Prostate Cancer. The 2025 retreat concluded with an impactful presentation from Dr. Artie Shelton, veteran and prostate cancer survivor, and an engaging poster session and award ceremony.
See our CPDR News page for more CPDR updates!
Gregory Chesnut, M.D., FACS CDR, MC, USN, with CPDR Overview: Prostate Cancer Care in the Equal Access DoD Healthcare System
Isla Garraway, M.D., Ph.D., Keynote Speaker: The VA Multi-OMICS Analysis Platform for Prostate Cancer (VA-MAPP) - Activating a Learning Healthcare System Model to Improve Outcomes for Veterans
Leigh Ellis, Ph.D., CPDR Scientific Director
CPDR Retreat Presenters L-R: Elise DeArment (CPDR), Dr. Beatriz German-Falcon (CPDR), Dr. Irfan Asangani (University of Pennsylvania), Dr. Gail Prins (University of Illinois, Chicago), Dr. Saul Priceman (University of Southern California), Dr. Isla Garraway, Keynote Address (University of California Los Angeles, VA Healthcare System), Dr. James Gulley (National Cancer Institute, National Institutes of Health), Dr. Clayton Yates (Johns Hopkins University), Dr. Gregory Chesnut (CPDR), Dr. Christopher Barbieri (Weill Cornell Medicine), Dr. Qianban Wang, Duke University School of Medicine), Dr. Massimo Loda (Weill Cornell Medicine).
CPDR Director Dr. Gregory Chesnut and Artie Shelton, M.D. COL(Ret.), Prostate Cancer Survivor Presenter, Prostate Health Education Network, INC (PHEN)
500+ scientific articles have been published in the past 32 years
259K biospecimen units collected from 800+ patients
31K military patients with prostate cancer data, integrated with 5 DoD and 1 civilian medical centers in Multicenter National Database Study
CPDR Groundbreaking Discoveries
CPDR Groundbreaking Discoveries
Developed and validated emerging diagnostic, prognostic, and therapeutic approaches through a long term (since 1993) bio-molecular specimen bank (230,000 units from 7000+ patients), e.g., ERG oncoprotein-based stratification of prostate cancer (PMID: 22331093) and Oncotype DX Prostate Cancer test (PMID: 25465337, PMID: 26723180).
CPDR WRNMMC
CPDR WRNMMC
Walter Reed National Military Medical Center
Building 19, 3rd Floor
4954 North Palmer Rd. Bethesda, MD 20889-5600
Phone: (301) 319-2900
Report abuse